Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Coronavirus disease 2019 (COVID-19) pandemic has spread worldwide rapidly and patients with cancer have been considered as a vulnerable group for this infection. This study aimed to examine the expressions of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in tumor tissues of six common cancer types. Materials and Methods The expression levels of ACE2 and TMPRSS2 in tumors and control samples were obtained from online databases. Survival prognosis and biological functions of these genes were investigated for each tumor type. Results There was the overexpression of ACE2 in colon and stomach adenocarcinomas compared to controls, meanwhile colon and prostate adenocarcinomas showed a significantly higher expression of TMPRSS2. Additionally, survival prognosis analysis has demonstrated that upregulation of ACE2 in liver hepatocellular carcinoma was associated with higher overall survival (hazard ratio, 0.65; p=0.016) and disease-free survival (hazard ratio, 0.66; p=0.007), while overexpression of TMPRSS2 was associated with a 26% reduced risk of death in lung adenocarcinoma (p=0.047) but 50% increased risk of death in breast invasive carcinoma (p=0.015). Conclusion There is a need to take extra precautions for COVID-19 in patients with colorectal cancer, stomach cancer, and lung cancer. Further information on other types of cancer at different stages should be investigated.
Abstract
Purpose Coronavirus disease 2019 (COVID-19) pandemic has spread worldwide rapidly and patients with cancer have been considered as a vulnerable group for this infection. This study aimed to examine the expressions of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in tumor tissues of six common cancer types. Materials and Methods The expression levels of ACE2 and TMPRSS2 in tumors and control samples were obtained from online databases. Survival prognosis and biological functions of these genes were investigated for each tumor type. Results There was the overexpression of ACE2 in colon and stomach adenocarcinomas compared to controls, meanwhile colon and prostate adenocarcinomas showed a significantly higher expression of TMPRSS2. Additionally, survival prognosis analysis has demonstrated that upregulation of ACE2 in liver hepatocellular carcinoma was associated with higher overall survival (hazard ratio, 0.65; p=0.016) and disease-free survival (hazard ratio, 0.66; p=0.007), while overexpression of TMPRSS2 was associated with a 26% reduced risk of death in lung adenocarcinoma (p=0.047) but 50% increased risk of death in breast invasive carcinoma (p=0.015). Conclusion There is a need to take extra precautions for COVID-19 in patients with colorectal cancer, stomach cancer, and lung cancer. Further information on other types of cancer at different stages should be investigated.
참고문헌 (21)
- Kim Sun Bean, "Interim Guidelines on Antiviral Therapy for COVID-19", Infection and Chemotherapy, 52(2), pp.281~304 (2020), 대한감염학회[DOI]
- Recovery Collaborative Group, "Dexamethasone in hospitalized patients with COVID-19 : preliminary report", N Engl J Med, 384, pp.693~704 (2021)
- Hoang Tung, "Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence", Infection and Chemotherapy, 52(3), pp.317~334 (2020), 대한감염학회[DOI]
- The Lancet, "COVID-19 vaccines : no time for complacency", Lancet, 396, pp.1607~ (2020)
- Hoang Tung, "Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis", Infection and Chemotherapy, 53(1), pp.13~28 (2021), 대한감염학회[DOI]
- Liu M, "Potential role of ACE2 in coronavirus disease 2019(COVID-19)prevention and management", J Transl Int Med, 8, pp.9~19 (2020)
- Gemmati D, "COVID-19 and individual genetic susceptibility", receptivity: role of ACE1, Int J Mol Sci, pp.2020, 21[DOI]
- Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2018", Cancer Research and Treatment, 50(2), pp.317~323 (2018), 대한암학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2019", Cancer Research and Treatment, 51(2), pp.431~437 (2019), 대한암학회
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2020", Cancer Research and Treatment, 52(2), pp.351~358 (2020), 대한암학회
- Tang Z, "GEPIA2 : an enhanced web server for large-scale expression profiling and interactive analysis", Nucleic Acids Res, 47, pp.W556~60 (2019)
- Kuleshov MV, "Enrichr : a comprehensive gene set enrichment analysis web server 2016 update", Nucleic Acids Res, 44, pp.W90~7 (2016)
- Liang W, "Cancer patients in SARS-CoV-2 infection : a nationwide analysis in China", Lancet Oncol, 21, pp.335~337 (2020)
- Lee LY, "COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments : a prospective cohort study", Lancet, 395, pp.1919~1926 (2020)
- Mehta V, "Case fatality rate of cancer patients with COVID-19 in a New York hospital system", Cancer Discov, 10, pp.935~941 (2020)
- Lin B, "Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2", Cancer Res, 59, pp.4180~4184 (1999)
- Ong EZ, "A dynamic immune response shapes COVID-19 progression", Cell Host Microbe, 27, pp.879~882 (2020)